Tainan, Taiwan-based ScinoPharm develops and manufactures active pharmaceutical ingredients (APIs). The company offers a full range of API services from process development, production of early phase clinical trial material to large-scale manufacturing for commercial launches.

As part of their long-term global expansion plans, ScinoPharm will open a new manufacturing plant in Changshu, China to provide cost-competitive development and manufacturing solutions for key intermediates and APIs.